Stretch and/or oxygen glucose deprivation (OGD) in an in vitro traumatic brain injury (TBI) model induces calcium alteration and inflammatory cascade

Ahn, 2004, The effects of traumatic brain injury on cerebral blood flow and brain tissue nitric oxide levels and cytokine expression, J. Neurotrauma, 21, 1431, 10.1089/neu.2004.21.1431

Albert-Weissenberger, 2010, Experimental traumatic brain injury, Exp. Transl. Stroke Med., 2, 1, 10.1186/2040-7378-2-16

Arend, 1991, Interleukin 1 receptor antagonist. A new member of the interleukin 1 family, J. Clin. Invest., 88, 1445, 10.1172/JCI115453

Atlee, 2007, Complications in Anesthesia

Audus, 1990, The use of cultured epithelial and endothelial cells for drug transport and metabolism studies, Pharm. Res., 7, 435, 10.1023/A:1015800312910

Audus, 1991, Transport of macromolecules across the capillary endothelium, Targeted Drug Delivery, 43, 10.1007/978-3-642-75862-1_3

Bell, 1997, Interleukin-6 and interleukin-10 in cerebrospinal fluid after severe traumatic brain injury in children, J. Neurotrauma, 7, 451, 10.1089/neu.1997.14.451

Berrout, 2011, Critical role of TRPP2 and TRPC1 channels in stretch-induced injury of blood-brain barrier endothelial cells, Brain Res., 1436, 1, 10.1016/j.brainres.2011.11.044

Blecharz, 2014, Inhibition of proteasome-mediated glucocorticoid receptor degradation restores nitric oxide bioavailability in myocardial endothelial cells in vitro, Biol. Cell, 106, 219, 10.1111/boc.201300083

Bolaños, 1999, Roles of nitric oxide in brain hypoxia-ischemia, Biochim. Biophys. Acta, 1411, 415, 10.1016/s0005-2728(99)00030-4

Brockmann, 2009, The expanding phenotype of GLUT-1 deficiency syndrome, Brain Dev., 31, 545, 10.1016/j.braindev.2009.02.008

Burek, 2014, Differential cytokine release from brain microvascular endothelial cells treated with dexamethasone and multiple sclerosis patient sera, J. Steroids Hormonal Sci., 5, 128, 10.4172/2157-7536.1000128

Burek, 2012, Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model, J. Vis. Exp., 66, e4022, 10.3791/4022

Cernak, 2005, Animal models of head trauma, NeuroRx, 2, 410, 10.1602/neurorx.2.3.410

Ceruti, 2011, Oxygen–glucose deprivation increases the enzymatic activity and the microvesicle-mediated release of ectonucleotidases in the cells composing the blood–brain barrier, Neurochem. Int., 59, 259, 10.1016/j.neuint.2011.05.013

Cherian, 2004, Nitric oxide in traumatic brain injury, Brain Pathol., 14, 195, 10.1111/j.1750-3639.2004.tb00053.x

Cheung, 1986, Ca2+ and ischemic injury, N. Engl. J. Med., 314, 314

Choi, 1988, Ca2+-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage, Trends Neurosci., 10, 465, 10.1016/0166-2236(88)90200-7

D'Atri, 2002, Molecular complexity of vertebrate tight junctions (Review), Mol. Membr. Biol., 19, 103, 10.1080/09687680210129236

Dinarello, 1991, Interleukin-1 and interleukin-1 antagonism, Blood, 77, 1627, 10.1182/blood.V77.8.1627.1627

Dubrovskyi, 2013, Measurement of local permeability at subcellular level in cell models of agonist- and ventilator-induced lung injury, Lab. Invest., 93, 254, 10.1038/labinvest.2012.159

Ellis, 1995, A new model for rapid stretch-induced injury of cells in culture: characterization of the model using astrocytes, J. Neurotrauma, 12, 325, 10.1089/neu.1995.12.325

Espinoza-Rojo, 2010, Glucose transporters regulation on ischemic brain: possible role as therapeutic target, Cent. Nerv. Sys. Agents Med. Chem., 10, 317, 10.2174/187152410793429755

Faraci, 1994, Cerebral vasodilation during hypercapnia. Role of glibenclamide-sensitive potassium channels and nitric oxide, Stroke, 25, 1679, 10.1161/01.STR.25.8.1679

Fineman, 1993, Concussive brain injury is associated with a prolonged accumulation of calcium: a 45Ca autoradiographic study, Brain Res., 624, 94, 10.1016/0006-8993(93)90064-T

Förster, 2008, Tight junctions and the modulation of barrier function in disease, Histochem. Cell Biol., 130, 55, 10.1007/s00418-008-0424-9

Förster, 2005, Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system, J. Physiol., 565, 475, 10.1113/jphysiol.2005.084038

Förstermann, 1998, Expressional control f the constitutive isoforms of nitric oxide synthase (NOS I and NOS III), FASEB, 12, 773, 10.1096/fasebj.12.10.773

Gaetz, 2004, The neurophysiology of brain injury, Clin. Neurophysiol., 115, 4, 10.1016/S1388-2457(03)00258-X

Gidday, 1999, Endogenous glutathione protects cerebral endothelial cells from traumatic injury, J. Neurotrauma, 16, 28, 10.1089/neu.1999.16.27

Gray, 2011, Current controversies in traumatic brain injury, Ann. Queenstown Update Anesth, 51

Haslam, 2000, Estimating the number of viable animal cells in multi-well cultures based on their lactate dehydrogenase activities, Cytotechnology, 32, 63, 10.1023/A:1008121125755

Hopkins, 1995, Cytokines and the nervous system. I: expression and recognition, Trends Neurosci., 18, 83, 10.1016/0166-2236(95)80029-2

Hovda, 1992, Secondary injury and acidosis, J. Neurotrauma, 9, S47

Jowers, 2013, The cell injury device: a high-throughput platform for traumatic brain injury research, J. Neurosci. Methods, 218, 1, 10.1016/j.jneumeth.2013.04.020

Kader, 1993, Nitric oxide production during focal cerebral ischemia in rats, Stroke, 24, 1709, 10.1161/01.STR.24.11.1709

Kleinschnitz, 2011, Glucocorticoid insensitivity at the hypoxic blood–brain barrier can be reversed by inhibition of the proteasome, Stroke, 42, 1081, 10.1161/STROKEAHA.110.592238

Kossmann, 1995, Intrathecal and serum interleukin-6 and the acute-phase response in patients with severe traumatic brain injuries, Shock, 4, 311, 10.1097/00024382-199511000-00001

Kumaria, 2008, In vitro models of neurotrauma, Br. J. Neurosurg., 22, 200, 10.1080/02688690701772413

Lucas, 2006, The role of inflammation in CNS injury and disease, Br. J. Pharmacol., 147, S232, 10.1038/sj.bjp.0706400

Maas, 2008, Moderate and severe traumatic brain injury in adults, Lancet Neurol., 7, 728, 10.1016/S1474-4422(08)70164-9

McKeon, 1997, Expression of full-length trkB receptors by reactive astrocytes after chronic CNS injury, Exp. Neurol., 148, 558, 10.1006/exnr.1997.6698

Mogi, 1994, Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from Parkinsonian patients, Neurosci. Lett., 180, 147, 10.1016/0304-3940(94)90508-8

Morales, 2005, Experimental models of traumatic brain injury: do we really need to build a better mousetrap?, Neuroscience, 136, 971, 10.1016/j.neuroscience.2005.08.030

Morrison, 2011, In vitro models of traumatic brain injury, Annu. Rev. Biomed. Eng., 13, 91, 10.1146/annurev-bioeng-071910-124706

Munaron, 2000, Calcium influx induced by activation of tyrosine kinase receptors in cultured bovine aortic endothelial cells, J. Cell. Physiol., 185, 454, 10.1002/1097-4652(200012)185:3%3C454::AID-JCP17%3E3.0.CO;2-A

Neuhaus, 2012, NMDA-receptor antagonist MK801 attenuates up-regulation of glucose uptake after oxygen/glucose deprivation in a blood-brain barrier in vitro model, Neurosci. Lett., 506, 44, 10.1016/j.neulet.2011.10.045

Neuhaus, 2014, The pivotal role of astrocytes in an in vitro stroke model of the blood-brain barrier, Front. Cell Neurosci., 8, 10.3389/fncel.2014.00352

Reinhart, 2002, Markers of endothelial damage in organ dysfunction and sepsis, Crit. Care Med., 30, S302, 10.1097/00003246-200205001-00021

Rothwell, 1995, Cytokines and the nervous system II: actions and mechanisms of action, Trends Neurosci., 18, 130, 10.1016/0166-2236(95)93890-A

Rubin, 1999, The cell biology of the blood-brain barrier, Annu. Rev. Neurosci., 22, 11, 10.1146/annurev.neuro.22.1.11

Rzigalinski, 1998, Intracellular free calcium dynamics in stretch-injured astrocytes, J. Neurochem., 70, 2377, 10.1046/j.1471-4159.1998.70062377.x

Rzigalinski, 1997, Effect of Ca2+ on in vitro astrocyte injury, J. Neurochem., 68, 289, 10.1046/j.1471-4159.1997.68010289.x

Salvador, 2013, Stretch in brain microvascular endothelial cells (cEND) as an in vitro traumatic brain injury model of the blood brain barrier, J. Vis. Exp., 80, e50928, 10.3791/50928

Shohamia, 1999, Dual role of tumor necrosis factor alpha in brain injury, Cytokine Growth Factor Rev., 10, 119, 10.1016/S1359-6101(99)00008-8

Silwedel, 2006, Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflamamtory stimuli, J. Neuroimmunol., 179, 37, 10.1016/j.jneuroim.2006.06.019

Sims, 2010, The IL-1 family: regulators of immunity, Nat. Rev. Immunol., 10, 89, 10.1038/nri2691

Thal, 2013, Inhibition of proteasomal glucocorticoid receptor degradation restores dexamethasone-mediated stabilization of the blood-brain barrier after traumatic brain injury, Crit. Care Med., 5, 1305, 10.1097/CCM.0b013e31827ca494

Touzani, 1999, Potential mechanisms of interleukin-1 involvement in cerebral ischaemia, J. Neuroimmunol., 100, 203, 10.1016/S0165-5728(99)00202-7

Vandamme, 2004, Tumour necrosis factor alpha inhibits purinergic calcium signalling in blood-brain barrier endothelial cells, J. Neurochem., 88, 411, 10.1046/j.1471-4159.2003.02163.x

Weber, 1999, Alterations in calcium-mediated signal transduction after traumatic brain injury of cortical neurons, Cell Calcium, 26, 289, 10.1054/ceca.1999.0082

Wolterbeek, 2005, Optimization, application, and interpretation of lactate dehydrogenase measurements in microwell determination of cell number and toxicity, Assay Drug Dev. Technol., 3, 675, 10.1089/adt.2005.3.675

Xiuli, 2005, Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood-brain barrier, Biochem. Genet., 43, 175, 10.1007/s10528-005-1510-5

Yu, 2010, Functional expression of SGLTs in rat brain, Am. J. Physiol. Cell Physiol., 299, C1277, 10.1152/ajpcell.00296.2010

Yu, 2011, Pro- and anti-inflammatory cytokine expression and histopathological characteristics in canine brain with traumatic brain injury, J. Vet. Sci., 12, 299, 10.4142/jvs.2011.12.3.299